Lymphoma, Follicular
specificA neoplasm of follicle centre B cells which has at least a partial follicular pattern. Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide. Most patients have widespread disease at diagnosis. Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present. The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)]. Histological grade correl
45
Centers
2
Active Trials
$889K
Cancer Funding
Top Centers for Lymphoma, Follicular(45)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | Stanford Cancer InstitutePalo Alto, CA NCI Comprehensive High-Volume Research Center | 89.7 |
| 2 | Medical College of Wisconsin Cancer CenterMilwaukee, WI High-Volume Research Center | 71.8 |
| 3 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 66.4 |
| 4 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive | 49.3 |
| 5 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive | 49.3 |
| 6 | Fred Hutch Cancer CenterSeattle, WA NCI Comprehensive | 49.3 |
| 7 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive | 49.3 |
| 8 | UNC Lineberger Comprehensive Cancer CenterChapel Hill, NC NCI Comprehensive | 49.3 |
| 9 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive | 49.3 |
| 10 | Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive | 49.3 |
| 11 | UC San Diego Moores Cancer CenterLa Jolla, CA NCI Comprehensive | 49.3 |
| 12 | NCI Comprehensive | 49.3 |
| 13 | NCI Comprehensive | 49.3 |
| 14 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive | 49.3 |
| 15 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive | 49.3 |
| 16 | Masonic Cancer CenterMinneapolis, MN NCI Comprehensive | 49.3 |
| 17 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive | 49.3 |
| 18 | University of Colorado Cancer CenterAurora, CO NCI Comprehensive | 49.3 |
| 19 | Moffitt Cancer CenterTampa, FL NCI Comprehensive | 49.3 |
| 20 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive | 49.3 |
| 21 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive | 49.3 |
| 22 | University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive | 49.3 |
| 23 | NCI Clinical | 49.3 |
| 24 | The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive | 49.3 |
| 25 | Cedars-Sinai CancerLos Angeles, CA | 49.3 |
| 26 | Cleveland Clinic Cancer CenterCleveland, OH | 49.3 |
| 27 | NCI Basic_laboratory | 49.3 |
| 28 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | 49.3 |
| 29 | The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive | 49.3 |
| 30 | Dartmouth Cancer CenterLebanon, NH NCI Comprehensive | 49.3 |
| 31 | Stephenson Cancer CenterOklahoma City, OK NCI Clinical | 49.3 |
| 32 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive | 49.3 |
| 33 | University of Illinois Cancer CenterChicago, IL | 49.3 |
| 34 | University of Hawai‘i Cancer CenterHonolulu, HI NCI Clinical | 49.3 |
| 35 | University of New Mexico Comprehensive Cancer CenterAlbuquerque, NM NCI Comprehensive | 49.3 |
| 36 | Fox Chase Cancer CenterPhiladelphia, PA NCI Comprehensive | 49.3 |
| 37 | Boston University Cancer CenterBoston, MA | 49.3 |
| 38 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive | 49.3 |
| 39 | Cancer Center at IllinoisUrbana, IL | 49.3 |
| 40 | Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ | 49.3 |
| 41 | Upstate Cancer CenterSyracuse, NY | 49.3 |
| 42 | Louisiana Cancer Research CenterNew Orleans, LA | 49.3 |
| 43 | 49.3 | |
| 44 | BC CancerVancouver, BC | 49.3 |
| 45 | Princess Margaret Cancer CentreToronto, ON | 49.3 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →